Open access · CC-BY
via OpenAlex
Mechanistic insights into pancreatic cancer progression from circadian rhythm disruption and gut microbiota dysbiosis (Review)
Yang Liu, Yongfeng Li, Heng Ma, Shichang Deng, Chao Cheng
International Journal of Molecular Medicine · 2026 · ▲ 2 citations
Abstract
Pancreatic cancer has nearly doubled in incidence over the past two decades, becoming one of the deadliest types of malignancy in humans, with poor prognosis.With advances in modern medicine, the 5-year survival rate for pancreatic cancer has increased from <5% in 1990 to ~10% in 2021.Most patients are diagnosed at an advanced stage, and ~20% of patients diagnosed at an early stage are eligible for surgical resection, with a 5-year survival rate after surgery of up to 25%.With the aging population, the incidence of pancreatic cancer is expected to continue rising.The gut microbiota, a crucial ecosystem, comprises >1x10 14 microorganisms that influence the development of pancreatic cancer through immune modulation and metabolites.circadian rhythms, as a conserved molecular feedback loop, regulate cell metabolism and immune function, and their dysregulation is associated with metabolic disorders and tumor progression.circadian rhythm disruption not only affects the gut microbiota and its metabolites but also accelerates pancreatic cancer progression through mechanisms such as promoting inflammation, immune suppression and drug resistance.The present review summarizes the impact of circadian rhythm dysregulation on the gut microbiota and its metabolites, specific microbiota associated with pancreatic cancer and their mechanisms in tumor progression and aims to deepen the understanding of the role of gut microbiota in pancreatic cancer treatment, providing a theoretical basis for future therapeutic strategies.Contents 1. Introduction 2. Methods 3. disruption of circadian rhythm and pancreatic cancer risk 4. circadian regulation of gut barrier microbiota and immunity in pancreatic cancer 5. Gut microbiota and pancreatic cancer 6. Hepatitis viruses and pancreatic cancer 7. Mechanisms of gut microbiota-mediated pancreatic cancer progression 8. conclusion
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3892/ijmm.2026.5744
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Liu, Y., Li, Y., Ma, H., Deng, S., & Cheng, C. (2026). Mechanistic insights into pancreatic cancer progression from circadian rhythm disruption and gut microbiota dysbiosis (Review). <em>International Journal of Molecular Medicine</em>. https://doi.org/10.3892/ijmm.2026.5744
Vancouver
Liu Y, Li Y, Ma H, Deng S, Cheng C. Mechanistic insights into pancreatic cancer progression from circadian rhythm disruption and gut microbiota dysbiosis (Review). International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5744.
BibTeX
@article{yang2026Mechan,
title = {Mechanistic insights into pancreatic cancer progression from circadian rhythm disruption and gut microbiota dysbiosis (Review)},
author = {Yang Liu and Yongfeng Li and Heng Ma and Shichang Deng and Chao Cheng},
journal = {International Journal of Molecular Medicine},
year = {2026},
doi = {10.3892/ijmm.2026.5744},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cancers 2019
Open access · CC-BY
EMT and Stemness—Key Players in Pancreatic Cancer Stem Cells
Acta Pharmaceutica Sinica B 2023
Open access · CC-BY
Targeting the blood–brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays
International Journal of Molecular Sciences 2021
Open access · CC-BY
Is There an Interconnection between Epithelial–Mesenchymal Transition (EMT) and Telomere Shortening in Aging?
Gastroenterology 2018
Preprint · OA
Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013
Open access · OA
Anoikis molecular pathways and its role in cancer progression
Archives of The Medicine and Case Reports 2023
Open access · CC-BY